How have NRC shares performed in 2024?

National Research's stock was trading at $39.56 at the start of the year. Since then, NRC shares have decreased by 13.1% and is now trading at $34.37. View the best growth stocks for 2024 here .

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our NRC earnings forecast .

How can I listen to National Research's earnings call?

National Research will be holding an earnings conference call on Wednesday, May 8th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 866-813-9403 with passcode "619474".

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) announced its quarterly earnings data on Tuesday, February, 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The business earned $38 million during the quarter. National Research had a net margin of 20.84% and a trailing twelve-month return on equity of 47.79%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research declared a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.12 per share on Monday, April 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Wednesday, March 27th. Read our dividend analysis for NRC .

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.44%. The dividend payout ratio is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC .

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com . Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO) , Enterprise Products Partners (EPD) , AbbVie (ABBV) , Dominion Energy (D) , Gilead Sciences (GILD) , Pfizer (PFE) , Toronto-Dominion Bank (TD) , Verizon Communications (VZ) , Wells Fargo & Company (WFC) and TD Ameritrade (AMTD) .

Who are National Research's major shareholders?

National Research's stock is owned by many different retail and institutional investors. Top institutional investors include Cardinal Capital Management (0.11%) and Azzad Asset Management Inc. ADV (0.11%). Insiders that own company stock include Amandla Mk Trust, Jona S Raasch and Kevin R Karas. View institutional ownership trends .

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does National Research have any subsidiaries?

The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute. Read More

NASDAQ:NRC

National Research (NRC) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free NRC Stock Alerts

$33.77

+0.90 (+2.74%)

(As of 03:14 PM ET)

Compare

Today's Range: $32.08
▼
$34.37
50-Day Range: $32.87
▼
$40.95
52-Week Range: $32.08
▼
$47.25

Volume: 34,977 shs
Average Volume: 72,237 shs
Market Capitalization: $805.41 million

P/E Ratio: 27.02
Dividend Yield: 1.42%
Price Target: N/A

Get National Research alerts:

National Research MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.22% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.16
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.78 out of 5 stars

Business Services Sector

277th out of 304 stocks

Commercial Physical Research Industry

11th out of 11 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for National Research.

3.0

Short Interest

Percentage of Shares Shorted
1.22% of the float of National Research has been sold short.
Short Interest Ratio / Days to Cover
National Research has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in National Research has recently increased by 5.77%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
National Research pays a meaningful dividend of 1.44%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
National Research does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of National Research is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NRC.

1.8

News and Social Media Coverage

News Sentiment
National Research has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for National Research this week, compared to 3 articles on an average week.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, National Research insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.00% of the stock of National Research is held by insiders.
Percentage Held by Institutions
47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of National Research is 27.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of National Research is 27.50, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 29.63.
Price to Book Value per Share Ratio
National Research has a P/B Ratio of 17.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Tips4Traders

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

[Click here to subscribe] and elevate your trading today.

About National Research Stock (NASDAQ:NRC)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NRC Stock News Headlines

April 19, 2024 | americanbankingnews.com

National Research (NASDAQ:NRC) Shares Gap Up to $34.36

April 18, 2024 | businesswire.com

National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet

April 19, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

April 17, 2024 | msn.com

Narendra Modi Is Preparing New Attacks on Democratic Rights

April 16, 2024 | msn.com

Province to conduct rare earth minerals survey near Swift Current

April 16, 2024 | finance.yahoo.com

St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

April 11, 2024 | msn.com

Will not accept CAA, NRC, Uniform Civil Code: Mamata

April 8, 2024 | theglobeandmail.com

Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development

April 19, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

April 4, 2024 | finance.yahoo.com

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

April 2, 2024 | businesswire.com

Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

March 30, 2024 | msn.com

CAA is a classic case of dead on arrival. It’ll be forgotten after 2024 elections

March 30, 2024 | msn.com

Game of Thrones star Emilia Clarke's mum backs National Rehabilitation Centre

March 28, 2024 | msn.com

Congress ramps pressure to speed up nuclear power development

March 27, 2024 | msn.com

Congress under pressure to speed up nuclear power development

March 27, 2024 | msn.com

Aerial footage shows scale of progress made on National Rehabilitation Centre

March 21, 2024 | finance.yahoo.com

Investors in National Research (NASDAQ:NRC) have unfortunately lost 5.2% over the last three years

March 18, 2024 | msn.com

US Senator expresses concern over notification of CAA rules

March 14, 2024 | markets.businessinsider.com

The U.S. Is Betting Big on Small Nuclear Reactors

March 14, 2024 | powermag.com

U.S., UK, Canada Ink Trilateral Memo to Cooperate on Advanced Reactor Licensing

March 14, 2024 | finance.yahoo.com

DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution

March 14, 2024 | yahoo.com

5 THINGS: Five questions about National Alcohol and Drugs Facts Week

March 11, 2024 | msn.com

Can CAA get BJP lots of votes? Depends

March 11, 2024 | msn.com

PSB M4U TWM wireless earbuds review: zero frills, stunning sound

March 11, 2024 | msn.com

Forget ‘Oppenheimer’ — nuclear power is having its moment in Washington

March 1, 2024 | finance.yahoo.com

National Research Full Year 2023 Earnings: EPS: US$1.26 (vs US$1.28 in FY 2022)

February 26, 2024 | msn.com

City Of St. Petersburg Extends Date To Complete Community Survey

See More Headlines

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/13/2024
Ex-Dividend for 4/15 Dividend: 3/27/2024
Dividend Payable: 4/15/2024
Today: 4/19/2024
Next Earnings (Confirmed): 5/07/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Business Services
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:NRC
CUSIP: N/A
CIK: 70487
Web: www.nrchealth.com
Phone: (402) 475-2525
Fax: 402-475-9061
Employees: 435
Year Founded: 1981

Profitability

EPS (Most Recent Fiscal Year): $1.25
Trailing P/E Ratio: 26.30
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $30.97 million
Net Margins: 20.84%
Pretax Margin: 26.90%
Return on Equity: 47.79%
Return on Assets: 24.27%

Debt

Debt-to-Equity Ratio: 0.60
Current Ratio: 0.67
Quick Ratio: 0.67

Sales & Book Value

Annual Sales: $148.58 million
Price / Sales: 5.28
Cash Flow: $1.50 per share
Price / Cash Flow: 21.89
Book Value: $2.02 per share
Price / Book: 16.27

Miscellaneous

Outstanding Shares: 23,850,000
Free Float: 23,377,000
Market Cap: $783.95 million
Optionable: Optionable
Beta: 0.42

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Michael D. Hays (Age 69)
Founder, CEO, President & Director
Comp: $131.65k
Ms. Helen L. Hrdy (Age 58)
Chief Customer Officer
Comp: $291.31k
Linda Stacy
Principal Accounting Officer
Mr. Christophe Louvion
Chief Product & Technology Officer
Mr. Andy Monnich
Chief Corporate Development Officer
Mr. Jon Boumstein
Chief Delivery Officer
Dr. Gregory Makoul M.S.
Ph.D., Chief Transformation Officer
Mr. Jason Hahn
Chief Revenue Officer
Megan Charko
Senior Manager of Content Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed in 2024?: National Research's stock was trading at $39.56 at the start of the year. Since then, NRC shares have decreased by 13.1% and is now trading at $34.37.
View the best growth stocks for 2024 here.
When is National Research's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our NRC earnings forecast.
How can I listen to National Research's earnings call?: National Research will be holding an earnings conference call on Wednesday, May 8th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 866-813-9403 with passcode "619474".
How were National Research's earnings last quarter?: National Research Co. (NASDAQ:NRC) announced its quarterly earnings data on Tuesday, February, 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The business earned $38 million during the quarter. National Research had a net margin of 20.84% and a trailing twelve-month return on equity of 47.79%.
How often does National Research pay dividends? What is the dividend yield for National Research?: National Research declared a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.12 per share on Monday, April 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for NRC.
Is National Research a good dividend stock?: National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.44%. The dividend payout ratio is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What is Michael D. Hays' approval rating as National Research's CEO?: 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.
What other stocks do shareholders of National Research own?: Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).
Who are National Research's major shareholders?: National Research's stock is owned by many different retail and institutional investors. Top institutional investors include Cardinal Capital Management (0.11%) and Azzad Asset Management Inc. ADV (0.11%). Insiders that own company stock include Amandla Mk Trust, Jona S Raasch and Kevin R Karas.
View institutional ownership trends.
How do I buy shares of National Research?: Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does National Research have any subsidiaries?: The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More

This page (NASDAQ:NRC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

National Research (NRC) Stock Price, News & Analysis

National Research MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About National Research Stock (NASDAQ:NRC)

NRC Stock Price History

NRC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

NRC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™